Use of heme arginate to manufacture a medicament for treating beta coronavirus infection

Abstract

The solution is to use heme arginate to manufacture a medicament for treating beta coronavirus infection, as heme arginate has been found to inhibit the replication of beta coronaviruses, especially SARS-CoV-2 and related beta coronaviruses SARS or MERS, while protecting infected cells from damage.

Keywords

• SARS-CoV-2
• beta coronaviruses
• heme arginate
• inhibition of replication
• immune modulation